Clinical Trials Browser

Phase 3 × Nalbuphine × Other hematologic neoplasm × Clear all

NCT03825887 2021-08-02

PCA

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute